Skip to main content
SpringerLink
Log in

Agents in Development for the Treatment of Hepatitis C

Summary and Table

  • Section 2: Depatitis C
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17: 1730–3

    Article  PubMed  CAS  Google Scholar 

  2. Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol 1999; 14 Suppl.: S1–5

    Article  PubMed  Google Scholar 

  3. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–62

    Article  PubMed  CAS  Google Scholar 

  4. Benhamou J-P, Rodes J, Alter H, et al. EASL international consensus conference on hepatitis C. Paris, 26–28 February 1999. Consensus statement. J Hepatol 1999; 30: 956–61

    Article  Google Scholar 

  5. Berenguer M, Wright TL. Hepatitis C and liver transplantation. Gut 1999; 45: 159–63

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International Limited, Auckland, New Zealand

    Chris Dunn, Michelle Wilde & Richelle Paterson

Authors
  1. Chris Dunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Wilde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richelle Paterson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunn, C., Wilde, M. & Paterson, R. Agents in Development for the Treatment of Hepatitis C. Drugs R&D 2, 259–264 (1999). https://doi.org/10.2165/00126839-199902040-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902040-00010

Keywords

Search

Navigation